IDEX Shares Fall After Lowered 2025 Outlook

IDEX Corporation reported second-quarter 2025 net sales of $865.4 million, up 7.2% year over year, and adjusted earnings per share of $2.07, both beating analyst estimates. Despite the strong quarter, the company lowered its full-year adjusted EPS guidance to $7.85–$7.95 from $8.10–$8.45, citing softer order trends and increased customer caution amid economic uncertainty. The Health & Science Technologies segment led with a 20% sales increase, while Fluid & Metering Technologies saw a 3% decline. Net income dropped 7% from the previous year due to higher amortization and interest expenses related to recent acquisitions. IDEX shares fell sharply after the guidance update and are now down about 19% year-to-date, underperforming the broader market. Management is prioritizing operational productivity and margin preservation amid ongoing economic headwinds and slower industrial demand.